![]() |
|
|
-Tocopherol in Ovariectomized Rats1

Department of Human Nutrition, Kansas State University, Manhattan, KS 66506;
* Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269; and
Lonza, Incorporated, Fair Lawn, NJ 07410
4To whom correspondence should be addressed. E-mail: sung.koo{at}uconn.edu.
| ABSTRACT |
|---|
|
|
|---|
-tocopherol (
TOH) in ovariectomized (OX) rats. OX adult rats were weight-matched and assigned to 2 groups fed a modified AIN-93G diet containing
TOH-stripped soybean oil without (CN) or with (+CN) supplemental CN at 150 mg/kg diet. At 5 wk, each rat with a lymph cannula was infused intraduodenally at 3.0 mL/h with a lipid emulsion consisting of 565 µmol triolein labeled with 14C (14C-OA), 3.6 µmol
TOH, and 396 µmol sodium taurocholate in 24 mL PBS buffer. Lymph was collected hourly for 8 h and analyzed for lipids. The lymphatic absorption of
TOH for 8 h in +CN rats (899 ± 201 nmol) was higher (P < 0.05) than in CN rats (587 ± 92 nmol). The absorption of 14C-OA in +CN rats (53.5 ± 4.0% dose/8 h) also was increased (P < 0.05) compared with CN rats (47.6 ± 5.0% dose/8 h). Lymph flow did not differ between the groups. When bile was diverted but with infusion of sodium taurocholate, the lymphatic absorption of lipids did not differ. The present study provides evidence that dietary CN enhances the rates and amounts of lymphatic absorption of
TOH and fat in OX rats. Our findings suggest that dietary CN may influence the process of lipid packaging and absorption by the enterocyte in OX rats, and may explain in part the increased status of
TOH in CN-fed animals.
KEY WORDS: carnitine fat intestinal absorption
-tocopherol ovariectomy rats
L-Carnitine (CN)5 plays an important role in the transfer of long-chain acyl groups into the mitochondrial matrix. Evidence suggests that CN has other biological functions (1). CN and acylcarnitines were shown to protect isolated perfused heart (2), cardiac microsomes (3), and cell membranes (4) and lipoproteins (5) from peroxidation. CN exhibits a free radicalscavenging activity (6), perhaps by directly chelating iron necessary for the generation of hydroxyl radicals (7,8). CN and acylcarnitines were also shown to be involved in reacylation and remodeling of membrane phospholipids (PL) and act as a secondary antioxidant to protect cell membranes (9,10). Several studies demonstrated that CN improves the body status of
-tocopherol (
TOH), a potent lipid-soluble antioxidant, protecting cellular membrane and plasma lipoproteins (11,12).
At present, little information exists on the mechanism underlying the effect of dietary CN on the nutritional status and metabolism of
TOH, especially in ovariectomized (OX) animals. Recent evidence indicates that CN, as a substrate for carnitine palmitoyltransferase (CPT), plays an important role in the synthesis of triacylglycerol (TG) for chylomicron formation in the enterocyte (13), suggesting that CN may enhance other fat-soluble nutrients such as
TOH. The concentrations of
TOH in the liver and other tissues are significantly higher in female rats than in males (1417), whereas ovariectomy decreases and estradiol replacement elevates the tissue concentrations of
TOH in OX rats (18). Using the OX rats as a model for the state of ovarian estradiol deficiency as in postmenopausal women, the present study was conducted to determine whether dietary CN influences the lymphatic absorption of fat and
TOH in OX rats, hence contributing to the improved body status of
TOH in rats fed supplemental dietary CN, as reported earlier (11,12).
| MATERIALS AND METHODS |
|---|
|
|
|---|
Dietary treatment and ovariectomy.
During wk 1 of acclimation, rats consumed ad libitum a nutritionally adequate AIN-93G diet (19) formulated by Dyets containing egg white in place of casein as the protein source. The mineral contents of the diet were adjusted according to the AIN recommendations with the use of egg white (20). The soybean oil of the diet contained 0.02% tert-butylhydroquinone and tocopherols (2.7 mg RRR d-
-tocopherol, 0.3 mg ß-tocopherol, 23.2 mg
-tocopherol, and 6.7 mg
-tocopherol per 70 g). The vitamin mix of the diet contained all-rac dl-
-tocopherol as the source of vitamin E. The rats had free access to deionized water (Millipore) delivered via a stainless steel watering system. Rats weighing 240 ± 9 g were food deprived for 16 h and ovariectomized under halothane anesthesia (2.0% halothane in 2.0 L oxygen/min) using a halothane vaporizer (Ohio Medical Products). After 1 wk postoperative recovery, OX rats were weight matched and assigned to 2 groups: one fed the AIN-93G diet containing
TOH-stripped soybean oil without L-carnitine (CN) or with (+CN) supplemental CN (Carniking®, Lonza) at 150 mg/kg diet. Carniking contained 50% CN in an approved food additive (Sipernat 50, a silica-derived anticaking agent) and the control (CN) diet was supplemented with Sipernat 50 (the vehicle). In the present study, the dosage of CN was set at 150 mg/kg diet. This amount of CN was estimated to be 0.01 mg/kJ on the basis of the rats daily food intake of 20 g (334 kJ), which is equivalent to a daily intake of 104.5 mg for a human consuming 10,450 kJ (2500 kcal)/d and is within the range of a typical diet providing 95135 mg CN/d (1).
Animal surgery.
After 5 wk of dietary treatment, rats weighing
325 g from each group were used. The effect of dietary CN on the intestinal absorption of
TOH and other lipids was examined in bile-intact and bile-diverted rats (21). After 16-h of food deprivation, rats were anesthetized with halothane. After a midline abdominal incision, the major mesenteric lymph duct was cannulated with vinyl tubing (0.50 mm i.d., 0.80 mm o.d.; SV 31, Dural Plastics & Engineering) and fixed with cyanoacrylate glue (Krazy Glue). An intraduodenal infusion catheter was installed by inserting silicone tubing (1.02 mm i.d., 2.16 mm o.d.; Silastic, Dow Corning Medical Products) through the gastric fundus into the proximal duodenum and secured with a purse-string suture. For the experiment with bile-diverted rats, the common bile duct was cannulated with PE-10 polyethylene tubing (0.28 mm i.d., 0.61 mm o.d.; Becton Dickinson, Clay Adams Brand), secured in situ with a purse-string suture. The lymph and bile duct cannulae and the infusion catheter were exteriorized through the right flank. After the incision was closed, rats were placed in individual restraining cages and allowed to recover for 2024 h in a recovery chamber maintained at 30°C. Immediately after surgery, glucose-PBS [in mmol/L: 277.0 D-(+)-glucose, 6.8 Na2HPO4, 16.5 NaH2PO4, 115.0 NaCl, and 5.0 KCl; pH 6.7] was continuously infused through the infusion catheter at 3.0 mL/h via a syringe infusion pump (Harvard Apparatus, Model 935).
Preparation and infusion of lipid emulsion.
After postoperative recovery, each rat was infused with a lipid emulsion at 3.0 mL/h via the duodenal catheter under subdued light. The lipid emulsion consisted of 3.6 µmol of
TOH (all-rac-
-tocopherol, 97%, Aldrich Chemical), 27.8 kBq of [carboxy-14C]-triolein (14C-OA; specific activity, 3.04.4 GBq/mmol, DuPont NEN), 565.0 µmol of triolein (95%, Sigma Chemical), and 396.0 µmol of sodium taurocholate in 24 mL of PBS. The amounts of triolein and
TOH provided in the lipid emulsion for an 8-h infusion were
33% of the daily intakes of a rat consuming 20.0 g/d of the AIN-93G diet that contains 7.0% fat (19). The amount of bile salt (sodium taurocholate) in the emulsion was set at 0.89%, which is adequate to emulsify the lipids, but considered safe with no detrimental effect on the intestinal absorptive function (22). Lymph was collected hourly under subdued light for 8 h in preweighed, ice-chilled, conical centrifuge tubes containing 30 µg of n-propyl gallate as an antioxidant and 4 mg of Na2EDTA as an anticoagulant. The tubes for bile collection contained 10 µg of n-propyl gallate. All samples were stored at 70°C until analysis.
TOH and lipid analysis.
Lymph or bile samples (100 µL), mixed with
TOH acetate as an internal standard, were extracted by 2 mL of acetone, and
TOH was analyzed by HPLC (21,23) using methanol as the mobile phase (24). Absorbance was monitored at 292 nm (Module 166, Beckman Instruments). Typical retention times were 4.1 min for
TOH and 5.3 min for
TOH acetate.
TOH was quantified based on the
TOH standard curve with a linear range between 110.5 and 442.3 pmol (r = 0.999). Total PL was measured colorimetrically (UV-1201 Spectrophotometer; Shimadzu Scientific Instruments) by the method of Reheja et al. (25). Total cholesterol (CH) was determined using o-phthalaldehyde (26).
Determination of 14C-OA absorption. Fresh lymph (100 µL) was mixed with scintillation liquid (ScintiVerse, Fisher Scientific) and 14C-radioactivity was determined by scintillation spectrometry (Beckman LS-6500, Beckman Instruments). The total 14C-radioactivity appearing in the lymph collected hourly was used to determine the amount of 14C-OA absorbed. The hourly rate of 14C-OA absorption was expressed as the percentage of the total dose of 14C-OA infused.
Statistical analysis. Values are presented as means ± SD unless otherwise stated. Repeated-measures ANOVA was performed by PC SAS to compare group means and to detect time-dependent changes within groups (27). When there was a significant treatment effect from repeated-measures ANOVA, differences (P < 0.05) among means were determined by Fishers protected least significant difference test.
| RESULTS |
|---|
|
|
|---|
Lymph flow and lymphatic absorption of
TOH.
In bile ductintact rats, the rates of lymph flow or total lymph volumes did not differ between groups (Table 1). The rates of lymph flow in +CN and -CN rats were 2.8 ± 0.7 mL/h and 3.1 ± 0.4 mL/h, respectively. At 2 h and thereafter, the rates of
TOH absorption differed significantly between groups (3.5 ± 0.3% dose/h in +CN and 2.3 ± 0.4% dose/h in CN rats) (Fig. 1A). The total absorption of
TOH for 8 h in +CN rats was significantly higher than in CN rats (Table 1).
|
|
TOH output did not differ between +CN (0.6 ± 0.2% dose/h) and CN (0.7 ± 0.1% dose/h) (Fig. 1B). Also, total absorption of
TOH for 8 h did not differ between +CN rats (168 ± 40 nmol, 4.7 ± 1.1% dose) and CN rats (175 ± 30 nmol, 4.9 ± 0.8% dose). Bile diversion significantly reduced the total amount of
TOH absorbed in both groups, relative to that in bile ductintact rats. Lymphatic absorption of 14C-OA and outputs of PL and CH. In bile duct-intact rats, the absorption of 14C-OA in +CN was higher (P < 0.05) compared with CN rats (Table 1). The lymphatic output of PL in +CN increased (P < 0.05) compared with CN rats (Table 1), whereas CH output did not differ between +CN and CN rats(Table 1).
In bile-diverted rats, the lymphatic outputs of 14C-OA, PL, and CH were significantly lowered. With bile diversion, 14C-OA absorption did not differ between +CN rats (27.7 ± 8.3% dose/8 h) and CN rats (25.5 ± 6.9% dose/8 h). PL output did not differ between +CN (11.2 ± 2.5 µmol/8 h) and CN rats (11.0 ± 2.0 µmol/8 h). Similarly, CH output did not differ between +CN (3.5 ± 1.2 µmol/8 h) and CN rats (3.6 ± 0.6 µmol/8 h).
Biliary secretion of
TOH, PL, and CH.
The biliary outputs of
TOH in +CN and CN rats were 32.7 ± 6.6 and 33.7 ± 5.4 nmol/8 h, respectively, with no difference between groups. Also, biliary outputs of PL did not differ between the groups (18.0 ± 3.0 in +CN vs. 17.7 ± 1.4 µmol/8 h in CN) or CH (4.7 ± 0.3 in +CN vs. 4.8 ± 0.8 µmol/8 h in CN).
| DISCUSSION |
|---|
|
|
|---|
TOH in rats (11,12), although the mechanism underlying such an effect of CN is far from clear. Our data here provide convincing evidence that supplemental dietary CN significantly increases the lymphatic absorption of
TOH and fat in OX rats. This observation may explain in part the increased status of
TOH in CN-fed animals.
CN serves as a substrate for CPTI, which facilitates the transport of long-chain fatty acyl moiety into the mitochondria and peroxisomes for ß-oxidation. Considerable evidence suggests that CN plays another important role in transferring long-chain acyl moiety for the synthesis of TG in such tissues as liver and intestine, which synthesize TG for export. In a recent study (28), CPT isoforms were identified in liver microsomes. TG synthesis, which occurs in the liver microsomal lumen, is CN dependent because CPT mediates the transport of the acyl group into the microsomal lumen where diacylglycerol acyltransferase II esterifies diacylglycerol to TG (29,30). Furthermore, a recent study (13) demonstrated that a similar CN-dependent pathway for TG synthesis exists in the rat intestine. When etomoxir, a specific inhibitor of CPT, was infused intraduodenally, the lymphatic output of TG via chylomicrons was dramatically reduced. A previous study using ligated rat intestinal segments showed that the absorption of palmitic acid was significantly decreased in the presence of D-carnitine, a competitive inhibitor of CPT (31). Our finding that dietary CN significantly enhances the intestinal absorption of fat is consistent with the concept that the intestinal synthesis of fat is a CN-dependent process, which may influence the subsequent formation of VLDL or chylomicrons. Although it is unknown how dietary CN may influence
TOH absorption, it is generally accepted that the absorptive process for
TOH follows the path of TG movement in the enterocyte (32).
At present, no information is available on whether dietary CN also influences intestinal synthesis of PL, which is needed for chylomicron formation. An earlier study (33) showed that rat liver microsomes utilize acylcarnitine as a substrate for PL synthesis. Our data here indicate that dietary CN significantly increases the lymphatic output of PL. The increased lymphatic output of PL is not attributable to an increase in biliary PL secretion because there was no change in the biliary secretion of PL in the +CN rats. This observation suggests that the increase in lymphatic PL output by dietary CN may be associated with an increase in intestinal synthesis and/or mobilization of PL during lipid packaging and chylomicron formation in the enterocyte.
Our data here showed that bile diversion abolishes the stimulatory effect of CN on lipid absorption. Previous studies showed that dietary CN is absorbed and transported to the liver via the portal vein, and excreted into the bile, mostly as acylcarnitine (34,35). Most (80%) of the biliary CN in rats and humans is acylcarnitine, one third of which is long-chain acylcarnitine (36). Long-chain acylcarnitine, incorporated into mixed micelles with bile acids (37), may increase micellar solubilization of fat and
TOH. Our preliminary data showed that a lipid emulsion containing propionyl- and lauroyl-CN did not significantly affect lipid absorption in rats under similar conditions (unpublished data). It remains to be determined whether longer-chain acylcarnitine improves the micellar solubilization and subsequent transfer of lipids to the enterocyte.
It is also possible that supplemental dietary CN may increase the biliary secretion of acylcarnitine, which is then hydrolyzed in the intestinal lumen and absorbed into the enterocyte. We observed a significant increase in the biliary output of total CN in rats fed the same level of dietary CN in a separate experiment (unpublished data). The increased availability of CN via this route may facilitate TG synthesis in the enterocyte via the process involving the microsomal CPT system (2830). It was shown that dietary CN increases the concentrations of free CN and acylcarnitine in the proximal segments of the small intestine in rats (38). Thus, dietary CN may improve the intestinal concentrations of CN and increase CPT activity, in particular, in OX rats with compromised CN status (39). It is possible that the intestinal availability of CN might have been affected by the overnight food deprivation before surgery and low energy intake during the postoperative recovery period in the present study. Whether the contribution of biliary CN to the intestine is altered under these conditions remains to be determined.
In summary, the present study provides the first evidence that dietary CN significantly enhances the lymphatic absorption of fat and
TOH, a fat-soluble vitamin, in OX rats. Further studies are required to elucidate the mechanism underlying the stimulatory effect of dietary CN on lipid absorption, and to determine whether dietary CN improves the status of
TOH and other fat-soluble vitamins in postmenopausal women or individuals with compromised CN status.
| FOOTNOTES |
|---|
-tocopherol in ovariectomized rats. FASEB J. 14: A505 (abs.)]. This work is part of [Koo, S. I., Gross, K. L. & Owen, K. Q. (2002) Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals. U.S. Patent no. 6,476,010].
2 Current address: Division of Endocrinology, Clinical Nutrition, and Vascular Medicine, School of Medicine, University of California, Davis, CA 95617. ![]()
3 Current address: Department of Food and Nutrition, Changwon National University, Changwon, Kyongnam, 641773, Korea. ![]()
5 Abbreviations used:
TOH,
-tocopherol; CH, cholesterol; CN, L-carnitine; +CN, diet with CN; CN, diet without CN; CPT, carnitine palmitoyltransferase; 14C-OA, triolein labeled with 14C; OX, ovariectomized; PL, phospholipids; TG, triacylglycerol. ![]()
Manuscript received 19 November 2004. Initial review completed 7 January 2005. Revision accepted 20 January 2005.
| LITERATURE CITED |
|---|
|
|
|---|
1. Rebouche, C. J. (1999) Carnitine. Shils, M. E. Olson, J. A. Shihe, M. Ross, A. C. eds. Modern Nutrition in Health and Disease 9th ed. 1999:505-512 Lippincott Williams & Wilkins Baltimore, MD .
2. Leipala, J. A., Bhatnagar, R., Pineda, E., Najibi, S., Massoumi, K. & Packer, L. (1991) Protection of the reperfused heart by L-propionylcarnitine. J. Appl. Physiol. 71:1518-1522.
3. Schinetti, M. L., Rossini, D., Greco, R. & Bertelli, A. (1987) Protective action of acetylcarnitine on NADPH-induced lipid peroxidation of cardiac microsomes. Drugs Exp. Clin. Res. 13:509-515.[Medline]
4. Bertelli, A., Conte, A., Ronca, G., Segnini, D. & Yu, G. (1991) Protective effect of propionyl carnitine against peroxidative damage to arterial endothelium membranes. Int. J. Tissue React. 13:41-43.[Medline]
5. Bertelli, A., Conte, A. & Ronca, G. (1994) L-Propionyl carnitine protects erythrocytes and low-density lipoproteins against peroxidation. Drugs Exp. Clin. Res. 20:191-197.[Medline]
6. Packer, L., Valenza, M., Serbinova, E., Starke-Reed, P., Frost, K. & Kagan, V. (1991) Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart. Arch. Biochem. Biophys. 288:533-537.[Medline]
7. Reznick, A. Z., Kagan, V. E., Ramsay, R., Tsuchiya, M., Khwaja, S., Serbinova, E. A. & Packer, L. (1992) Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of chelation. Arch. Biochem. Biophys. 296:394-401.[Medline]
8. Vanella, A., Russo, A., Acquaviva, R., Campisi, A., Di Giacomo, C., Sorrenti, V. & Barcellona, M. L. (2000) L-Propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol. Toxicol. 16:99-104.[Medline]
9. Arduini, A., Mancinelli, G., Radatti, G. L., Dottori, S., Molajoni, F. & Ramsay, R. R. (1992) Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatty acid turnover in intact human erythrocytes. J. Biol. Chem. 267:12673-12681.
10. Ramsay, R. R. & Arduini, A. (1993) The carnitine acyltransferases and their role in modulating acyl-coA pools. Arch. Biochem. Biophys. 302:307-314.[Medline]
11. Kalaiselvi, T. & Panneerselvam, C. (1998) Effect of L-carnitine on the status of lipid peroxidation and antioxidants in aging rats. J. Nutr. Biochem. 9:575-581.
12. Dayanandan, A., Kumar, P. & Panneerselvam, C. (2001) Protective role of L-carnitine on liver and heart lipid peroxidation in atherosclerotic rats. J. Nutr. Biochem. 12:254-257.[Medline]
13. Washington, L., Cook, G. A. & Mansbach, C. M. (2003) Inhibition of carnitine palmitoyltransferase in the rat small intestine reduces export of triacylglycerol into the lymph. J. Lipid Res. 44:1395-1403.
14. Weglicki, W. B., Luna, Z. & Nair, P. P. (1969) Sex and tissue specific differences in concentrations of
-tocopherol in mature and senescent rats. Nature (Lond.) 221:185-185.[Medline]
15. Chen, H. W., Cook, L. R. & Hendrich, S. (1992) Gender and dietary fat affect
-tocopherol status in F344/N rats. Lipids 27:844-846.[Medline]
16. Feingold, I. B., Longhurst, P. A. & Colby, H. D. (1993) Regulation of adrenal and hepatic
-tocopherol content by androgens and estrogens. Biochim. Biophys. Acta 1176:192-196.[Medline]
17. Chung, H. J. & Koo, S. I. (1998) Estradiol replacement elevates the serum and tissue levels of
-tocopherol in ovariectomized rats. J. Nutr. Biochem. 9:67-74.
18. Noh, S. K., Koo, S. I. & Jeon, I. K. (1999) Estradiol replacement in ovariectomized rats increases the hepatic concentration and biliary secretion of
-tocopherol and polyunsaturated fatty acids. J. Nutr. Biochem. 10:110-117.[Medline]
19. Reeves, P. G., Nielsen, F. H. & Fahey, G. C., Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123:1939-1951.
20. Reeves, P. G. (1996) AIN-93 purified diets for the study of trace element metabolism in rodents. Watson, R. R. eds. Trace Elements in Laboratory Rodents 1996:3-37 CRC Press Boca Raton, FL. .
21. Koo, S. I. & Noh, S. K. (2001) Phosphatidylcholine inhibits and lysophosphatidylcholine enhances the lymphatic absorption of
-tocopherol in adult rats. J. Nutr. 131:717-722.
22. Tso, P., Balint, J. A. & Simmons, W. J. (1977) Role of biliary lecithin in lymphatic transport of fat. Gastroenterology 73:1362-1367.[Medline]
23. Zaspel, B. J. & Csallany, A. S. (1983) Determination of alpha-tocopherol in tissues and plasma by high-performance liquid chromatography. Anal. Biochem. 130:146-150.[Medline]
24. Liu, J. F. & Huang, C. J. (1995) Tissue
-tocopherol retention in male rats is compromised by feeding diets containing oxidized frying oil. J. Nutr. 125:3071-3080.
25. Raheja, R. K., Kaur, C., Singh, A. & Bhatia, I. S. (1973) New colorimetric method for the quantitative estimation of phospholipids without acid digestion. J. Lipid Res. 14:695-697.[Abstract]
26. Rudel, L. L. & Morris, M. D. (1973) Determination of cholesterol using o-phthalaldehyde. J. Lipid Res. 14:364-366.[Abstract]
27. SAS & Institute, Inc (1996) SAS Users Guide 1996 SAS Institute Cary, NC.
28. Murthy, M.S.R. & Pande, S. V. (1994) Malonyl-CoA-sensitive and -insensitive carnitine palmitoyltransferase activities of microsomes are due to different proteins. J. Biol. Chem. 269:18283-18286.
29. Owen, M. R., Corstorphine, C. C. & Zammit, V. A. (1997) Overt and latent activities of diacylglycerol acyltransferase in rat liver microsomes: possible roles in very-low-density lipoprotein triacylglycerol secretion. Biochem. J. 323:17-21.
30. Abo-Hashema, K.A.H., Cake, M. H., Power, G. W. & Clarke, D. (1999) Evidence for triacylglycerol synthesis in the lumen of microsomes via a lipolysis-esterification pathway involving carnitine acyltransferases. J. Biol. Chem. 274:35577-35582.
31. Leichter, J., Ottem, A. & Hahn, P. (1987) Does carnitine have a role in fat absorption?. Life Sci 41:941-944.[Medline]
32. Kayden, H. J. & Traber, M. G. (1993) Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J. Lipid Res. 34:343-358.[Medline]
33. Mok, A. Y. & McMurray, W. C. (1990) Biosynthesis of phosphatidic acid by glycerophosphate acyltransferases in rat liver mitochondria and microsomes. Biochem. Cell Biol. 68:1380-1392.[Medline]
34. Gudjonsson, H., Li, B.U.K., Shug, A. L. & Olsen, W. A. (1985) In vivo studies of intestinal carnitine absorption in rats. Gastroenterology 88:1880-1887.[Medline]
35. Gudjonsson, H., Li, B.U.K., Shug, A. L. & Olsen, W. A. (1985) Studies of carnitine metabolism in relation to intestinal absorption. Am. J. Physiol. 248:G313-G319.[Medline]
36. Hamilton, J. J. & Hahn, P. (1987) Carnitine and carnitine esters in rat bile and human duodenal fluid. Can. J. Physiol. Pharmacol. 65:1816-1820.[Medline]
37. Park, G. B., Shao, Z. & Mitra, A. K. (1992) Acyclovir permeation enhancement across intestinal and nasal mucosae by bile salt-acylcarnitine mixed micelles. Pharm. Res. 9:1262-1267.[Medline]
38. Sachan, D. S. & Ruark, R. A. (1985) Distribution of carnitine and acylcarnitine in small intestine of carnitine-supplemented and fasted rats. J. Nutr. 115:865-871.
39. Chiu, K. M., Schmidt, M. J., Shug, A. L., Binkley, N. & Gravenstein, S. (1997) Effect of dehydroepiandrone sulfate on carnitine acetyl transferase activity and L-carnitine levels in oophorectomized rats. Biochim. Biophys. Acta 1344:201-209.[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||